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The 4G family of eukaryotic mRNA translation initiation factors is composed of three
members (eIF4GI, eIF4GII, and DAP5). Their specific roles in translation initiation
are under intense investigations, but how their respective intracellular amounts are
controlled remains poorly understood. Here we show that eIF4GI and eIF4GII exhibit
much shorter half-lives than that of DAP5. Both eIF4GI and eIF4GII proteins, but not
DAP5, contain computer-predicted PEST motifs in their N-termini conserved across
the animal kingdom. They are both sensitive to degradation by the proteasome. Under
normal conditions, eIF4GI and eIF4GII are protected from proteasomal destruction
through binding to the detoxifying enzyme NQO1 [NAD(P)H:quinone oxidoreductase].
However, when cells are exposed to oxidative stress both eIF4GI and eIF4GII, but not
DAP5, are degraded by the proteasome in an N-terminal-dependent manner, and cell
viability is more compromised upon silencing of DAP5. These findings indicate that the
three eIF4G proteins are differentially regulated by the proteasome and that persistent
DAP5 plays a role in cell survival upon oxidative stress.
Keywords: mRNA translation, eIF4G, DAP5, PEST, NQO1, NRF2, proteasome, oxidative stress
INTRODUCTION
In eukaryotes, most nuclear encoded mRNAs are modified at their 5′ end with a cap-structure
(m7GpppN, where N is any nucleotide). Once mRNA has been exported to the cytoplasm, one
function of the cap is to facilitate mRNA translation into protein by the ribosome. Ribosomes
are recruited at the mRNA 5′ cap by eIF4F (reviewed in Merrick, 2015), a complex composed
of three proteins: the cap-binding protein eIF4E, the RNA-helicase eIF4A and the scaffolding
protein eIF4G which interacts with both eIF4E and eIF4A. eIF4G also interacts directly with
eIF3, a translation initiation factor bound to the small ribosomal subunit, and with the poly(A)
binding protein (PABP). Thus, through multiple interactions, eIF4G plays a central role in cap-
dependent translation initiation by bridging the mRNA 5′ cap structure (via eIF4E) to the poly(A)
tail (via PABP), and to the ribosome (via eIF3).
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Two eIF4G protein homologs have been characterized: eIF4GI
and eIF4GII (Gradi et al., 1998). Although both clearly function
in translation initiation, they differ in various aspects. Distinct
phosphorylation sites targeted by different signaling pathways
and with specific biological functions have been mapped in both
amino-acid sequences. For instance, both eIF4GI and eIF4GII
interact with the MAPK-interacting protein kinases MNK1
(Pyronnet et al., 1999) or MNK2 (Scheper et al., 2001), but only
eIF4GI has been described as an MNK1/2 substrate (Orton et al.,
2004). A third more distant protein homolog termed DAP5 (also
called NAT1, eIF4GIII, or p97) has been identified (Imataka
et al., 1997). The DAP5 polypeptide is devoid of N-terminal
PABP- and eIF4E-binding sites but possesses domains interacting
with eIF4A, eIF3 (Imataka et al., 1997) and MNK1/2 (Pyronnet
et al., 1999). Consistently, DAP5 has been implicated in the
specific translational regulation of a subset of mRNAs (Lee and
McCormick, 2006) and in eIF4E-independent translation when
cap-dependent translation is altered such as upon exposure
to different stresses (Nevins et al., 2003). The three members
of the eIF4G family thus appear to serve as fine regulators
of translation initiation under various physiological or stress
conditions. However, how the steady state level of each protein
is controlled and whether they can be differentially targeted to
degradation upon stress remain poorly understood.
MATERIALS AND METHODS
Cell Culture and Compounds
NIH-3T3 cells were grown in standard conditions as described
previously (Galés et al., 2003). To obtain cells expressing
significantly low levels of DAP5, HEK-293 cells grown in
standard conditions were first used to produce viruses upon
transfection of the packaging plasmids pPAX2 and pMD2,
and a pTRIPZ vector containing a tetracycline-inducible
promoter driving the expression of the TurboRFP fluorescent
reporter (GE Dharmacon Technology). ShRNAs directed
against DAP5 (sh1-DAP5: 5′-TACCTCTAGTAATGGGCT
TTA-3′ and sh2-DAP5: 5′-AACCAGCCAAAGCCTTAAATT-3′)
or a non-silencing scrambled sequence (shNS: 5′-AATTCT
CCGAACGTGTCACGT-3′) were cloned into pTRIPZ using
EcoRI and XhoI restriction sites. NIH-3T3 cells were transduced
with cell-free virus-containing supernatants and selected
against 4 µg mL−1 puromycin during 48 h. RFP-positive and
puromycin resistant cells were sorted (MoFlo XDP, Beckman)
to establish derivative pools with stable expression of the
shRNA constructs. As compared to shNS, the concentration of
doxycycline producing an optimal down-regulation of DAP5 in
both sh1-DAP5 and sh2-DAP5 cells was 4 µg mL−1. Puromycin,
doxycycline, cycloheximide, lactacystin, MG-132, dicumarol and
H2O2 were from Sigma and they were dissolved as recommended
by the manufacturer.
MTT Assay
For each condition, triplicates of native or stably transfected
NIH-3T3 cells seeded in 96-well plates were let grown for 24 h,
treated with or without 4 µg mL−1 doxycycline for 48 h and
incubated in the absence or presence of H2O2 for 16 or 24-h.
Cell survival was monitored by measuring absorbance at 570 nM
with a microplate reader (Mithras-LB-940, Berthold) next to
incubation with MTT (Euromedex).
Plasmids and Transient Transfections
Plasmids (depicted in Figure 2A) used for transient transfections
of NIH-3T3 cells were described earlier (Pyronnet et al.,
1999) and are as follows: pcDNA3-HA-eIF4GI, pcDNA3-
HA-eIF4GII and pcDNA3-HA-DAP5 (encoding full length
proteins); pcDNA3-HA-4GI-N and pcDNA3-HA-4GII-N
(encoding N-terminal fragments of eIF4GI and eIF4GII).
pcDNA3-HA-4GII-C containing the C-terminal two-thirds of
eIF4GII was constructed by insertion of a EcoRI-XhoI PCR
fragment amplified from the pcDNA3-HA-eIF4GII using the
forward catgacGAATTCcgactttacaccagcctttgct and reverse
catgacCTCGAGttttagttatcctcagactcctc primers. The NQO1
expression plasmid was as described previously (Alard et al.,
2009). Transient transfections of NIH-3T3 cells was carried
out with GeneJetTM (SignaGen Laboratories) according to the
manufacturer’s instructions. Proteins were expressed for 36 h
and cells were either processed immediately for immunoblotting
or processed following treatment with various compounds
(where indicated).
Co-immunoprecipitation and
Immunoblot Analyses
Preparation of cell extracts, co-immunoprecipitation and
immunoblotting were carried out as previously described
(Pyronnet et al., 1999). The antibodies used were as follows:
anti-eIF4GI and anti-eIF4GII (gifts of Prof. Nahum Sonenberg);
anti-DAP5 (CliniSciences #610742); anti-HA-7 (Sigma); anti-
β-tubulin (GeneTex #6288022); anti-4E-BP1, anti-NRF2 and
anti-p53 (Cell Signaling Technologies #9452, #12721, and #1C12,
respectively); anti-Core 20S (Enzo Life Sciences #PW8155); and
anti-NQO1 (Santa Cruz #C19).
Protein Sequences Analyses
To test for the presence of potential PEST motifs, amino-acid
sequences of eIF4GI, eIF4GII and DAP5 from different animal
species (described in Table 1) were up-loaded into the ePESTfind
software at EMBOSS explorer1. After running out the ePESTfind
software, only the potential PEST motifs displaying a score
>5.0 were taken into account in this study. The alignment
showing conservations between eIF4GI and eIF4GII sequences
was performed using the LALIGN program2.
RESULTS
eIF4GI and eIF4GII Exhibit Shorter
Half-Lives Than DAP5
To explore how the amounts of the three different eIF4G family
members are controlled, their respective half-lives were first
1http://emboss.bioinformatics.nl/cgi-bin/emboss/epestfind
2https://embnet.vital-it.ch/software/LALIGN_form.html
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TABLE 1 | Species and accession numbers of the eIF4G family
members analyzed.
Species (branch) Protein name Accession number
Home sapiens (mammals) eIF4GI AAI40897.1
eIF4GII AAI36644.1
DAP5 AAI11416.1
Gallus gallus (birds) eIF4GI XP_015147015.1
eIF4GII XP_015152751.1
DAP5 NP_001093330.1
Alligator sinensis (reptiles) eIF4GI XP_014383304.1
eIF4GII XP_025059396
DAP5 XP_025052452.1
Xenopus tropicalis (amphibians) eIF4GI XP_012818831.1
eIF4GII NP_001135544.1
DAP5 NP_001004992.1
Danio rerio (fishes) eIF4GI NP_001073669.1
eIF4GII XP_021325628.1
DAP5 NP_001014311.1
Drosophila melanogaster (insects) eIF4GI AAF59403.3
eIF4GII AAF56194.2
DAP5 AAF58443.2
monitored in non-transformed NIH-3T3 fibroblasts. Cells were
treated with cycloheximide (CHX) to arrest protein synthesis
and time-dependent decreases in the cellular contents of
eIF4GI, eIF4GII, and DAP5 were visualized by western-blotting.
Protein synthesis was efficiently blocked by CHX as attested
by a metabolic labeling of cells with puromycin and its
subsequent detection into nascent polypeptides by western-
blotting (Figure 1A, left). Both eIF4GI and eIF4GII exhibited
short half-lives (∼5 and ∼3 h, respectively) as compared to
DAP5 which remained unaltered after 8 h of treatment with
CHX (Figure 1A, middle and right). One probable explanation
for the relative short half-lives of eIF4GI and eIF4GII in cells is
that they are rapidly degraded by the proteasome. Consistently,
eIF4GI has been shown earlier to be a proteasomal substrate
with a relative short half-life (Baugh and Pilipenko, 2004).
We therefore tested this possibility by incubating cells with
MG-132, a specific proteasome inhibitor. Both eIF4GI and
eIF4GII markedly accumulated in cells following treatment
with MG-132 while the amount of DAP5 increased only
slightly over the same period (Figure 1B). Furthermore, the
fast decrease in eIF4GI or eIF4GII amount observed upon
inhibition of protein synthesis by CHX was less pronounced
when cells were co-incubated with MG-132 (Figure 1C).
These data indicate that eIF4GI and eIF4GII exhibit faster
turnovers than DAP5 in growing fibroblasts likely due to more
rapid degradation by the proteasome (and probably higher
rates of synthesis).
Involvement of PEST-Containing eIF4GI
or eIF4GII N-Terminus in Proteasomal
Degradation
We then searched how eIF4GI, eIF4GII, and DAP5 are
differentially targeted to the proteasome for degradation. eIF4GI
FIGURE 1 | Differential half-lives of eIF4GI, eIF4GII and DAP5. (A) NIH-3T3 cells were treated at different times with 50 µg mL−1 cycloheximide (CHX) and incubated
with 10 µg mL−1 puromycin (puro) 10 min before lysis. Proteins were visualized by western-blotting with the indicated antibodies (left and middle) and signals were
quantified by densitometric analysis (right). Data are the means ± SD of three separate experiments. (B) NIH-3T3 cells were treated at different times with 20 µM
MG-132 and proteins visualized by western-blotting as indicated. (C) NIH-3T3 cells were co-treated at different times with 50 µg mL−1 CHX and 20 mM MG-132
and proteins visualized by western-blotting as indicated.
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FIGURE 2 | Identification of PEST regulatory motifs in eIF4GI and eIF4GII N-termini. (A) Schematic representation of eIF4G protein family members highlighting the
binding domains with their main partners (colored boxes) and N-terminal third and C-terminal two thirds of eIF4GI and eIF4GII proteins (brackets) (top). Schematic
representation of HA-tagged (black boxes) full-length and deletion fragments used for transient transfections. The computer-predicted (ePEST-find, EMBOSS) PEST
motifs detected in eIF4GI and eIF4GII are numbered 1–5 (middle). Scores and locations of the five PESTs found in eIF4GI and eIF4GII polypeptides (bottom).
(B) Following transfection with HA-tagged full-length (left) or N-terminal (right) cDNAs, NIH-3T3 cells were untreated or treated at different times with 50 µg mL−1
CHX or MG-132 and proteins visualized by western-blotting as indicated. (C) Following transfection with HA-eIF4GII (top), HA-DAP5 (middle), or HA-eIF4GII-C
(bottom) cDNAs, NIH-3T3 cells were untreated or treated at different times with 50 µg mL−1 CHX and proteins visualized by western-blotting as indicated.
and eIF4GII are considered as two functional homologs because
they both contain domains interacting with key translation
initiation factors (including PABP, eIF4E, eIF3, and eIF4A)
and with the translation regulators MNK1 and MNK2 kinases.
The more distant homolog DAP5 shows similarities only
with the C-terminal two thirds of eIF4GI or eIF4GII as
it lacks the N-terminal third and as a consequence cannot
interact with PABP or eIF4E (Figure 2A, top). We therefore
suspected that N-terminal features shared only by eIF4GI and
eIF4GII could be responsible for their more rapid turnovers.
In silico predictions (ePESTfind, EMBOSS) revealed the existence
of five putative PEST-motifs (sequences enriched in proline,
glutamate, serine and threonine) with variable scores in each
eIF4GI and eIF4GII polypeptides. Similar computer-predicted
PEST motifs were identified earlier in the eIF4GI amino acid
sequence (Anand and Gruppuso, 2005). Five and four PEST
motifs were detected in the N-terminal thirds of eIF4GI and
eIF4GII, respectively, while one with a low score was found in
the C-terminal two-thirds of eIF4GII (Figure 2A, middle and
bottom). In contrast, no sequences reaching computer-predicted
PEST requirements could be detected in the DAP5 polypeptide.
PEST-motifs are known to target proteins for degradation by
the proteasome either dependently on or independently of
ubiquitination (Mathes et al., 2008). They have been found and
validated in other key short-lived proteins including c-MYC
(Gregory and Hann, 2000), members of the I-kappaB family
(Lin et al., 1996; Park et al., 2014) and ornithine decarboxylase
(ODC) (Ghoda et al., 1992). To test for their implication in
the fast turnovers of eIF4GI and eIF4GII, experiments designed
to monitor protein half-lives and similar to those described in
Figure 1 were repeated using HA-tagged full-length eIF4GI,
eIF4GII, and DAP5 (named HA-4GI, HA-4GII, and HA-DAP5;
Figures 2A, middle), or HA-tagged N-terminal segments of
eIF4GI and eIF4GII each containing 5 or 4 PEST motifs (named
HA-4GI-N and HA-4GII-N; Figure 2A, middle). Following
transfection and CHX treatment, HA-4GI and HA-4GII exhibited
half-lives as short as those observed for the endogenous proteins,
while HA-DAP5 devoid of PEST motifs remained unaltered
(Figure 2B, left). In addition, HA-4GI-N and HA-4GII-N were
also similarly short-lived upon inhibition of protein synthesis by
CHX, but accumulated upon inhibition of proteasomal activity by
MG-132 (Figure 2B, right). In contrast, HA-4GII-C containing
the C-terminal two-thirds of eIF4GII but lacking its N-terminal
third was more resistant to degradation upon CHX treatment,
and showed a stability similar to that of HA-DAP5 (Figure 2C).
These data suggest that PEST-containing N-terminal thirds of
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FIGURE 3 | eIF4GI and eIF4GII, but not DAP5, are degraded under oxidative stress. (A) NIH-3T3 cells were untreated or treated with increasing concentration of
H2O2 in the presence or absence of lactacystin (described in Alard et al., 2009), and protein extracts were subjected to western-blotting as indicated. (B) NIH-3T3
cell extracts were subjected to western-blotting with the indicated antibodies either directly (input) or after immunoprecipitation (IP) with either eIF4GI or eIF4GII
antibodies (left). NIH-3T3 extracts of cells either untransfected of transfected with NQO1 cDNA were subjected to western-blotting with the indicated antibodies
either directly (input) or after immunoprecipitation (IP) with NQO1 antibodies (right). (C) NIH-3T3 cells were untreated or treated with 300 µM dicumarol (Dic) at
different times and proteins were visualized by western-blotting as indicated. (D) Following transfection with HA-tagged, full-length or N-terminal cDNAs, NIH-3T3
cells were untreated or treated with 300 µM dicumarol for 8 h and proteins visualized by western-blotting as indicated.
eIF4GI and eIF4GII form signals sufficient for targeting them to
proteasomal degradation.
DAP5 Is Resistant to Degradation
Under Oxidative Stress
eIF4GI can be destructed directly by the 20S proteasome
(Baugh and Pilipenko, 2004) and we (Alard et al., 2009) and
others (Attar-Schneider et al., 2014) have shown that it is
protected from degradation through its binding to NQO1,
an observation made initially for the two other short-lived
proteins p53 (Asher et al., 2003) and ODC (Asher et al., 2005);
and more recently extended to other key proteins including
HIF-1α (Oh et al., 2016). NQO1 protects candidate proteins from
degradation by the proteasome through its direct interaction
with the 20S proteasome (Moscovitz et al., 2012). However,
upon oxidative stress which recruits NQO1 and its quinone
oxidoreductase activity for detoxifying reactive oxygen species,
eIF4GI (and other protected proteins) no longer binds to
NQO1 and becomes more rapidly degraded by the proteasome
(Alard et al., 2009). To check whether a similar degradation
of eIF4GII or DAP5 occurs, the fate of both proteins was
monitored under oxidative stress. Increasing concentrations
of H2O2 resulted in a degradation of eIF4GII sensitive to
the proteasome inhibitor lactacystin, while the amount of
DAP5 remained unchanged (Figure 3A). This suggested that
eIF4GII is subjected to a similar mechanism of deregulation
than that of eIF4GI under oxidative stress. The possibility
that eIF4GII also interacts with NQO1 has been therefore
verified. Co-immunoprecipitation experiments confirmed the
interaction between eIF4GI and NQO1 (Figure 3B, left), and
revealed that eIF4GII similarly interacts with NQO1 when
co-immunoprecipitation is performed with either anti-eIF4GII
(Figure 3B, middle) or anti-NQO1 (Figure 3C, right) antibodies.
The protective binding of NQO1 to eIF4GI (Alard et al., 2009),
p53 (Asher et al., 2003), and ODC (Asher et al., 2005) is disrupted
by dicumarol, an NQO1-specific inhibitor which provokes the
accumulation of intracellularly produced ROS. Consistently,
incubation of cells with dicumarol provoked the degradation
of eIF4GI and eIF4GII, while the amount of DAP5 was not
affected (Figure 3C). p53 was used here as positive control
of protein degradation induced by dicumarol (Figure 3C),
although its degradation and recovery followed faster kinetics
than those of eIF4GI or eIF4GII. In addition, HA-tagged full-
length as well as N-terminal thirds of both eIF4GI and eIF4GII
were all degraded next to dicumarol treatment (Figure 3D),
indicating that PEST-containing N-terminal domains of the two
homologs are sufficient to mediate proteasomal degradation
under oxidative stress.
DAP5 Is Involved in Cell Survival
Under Oxidative Stress
Because DAP5, but not eIF4GI or eIF4GII, was unaffected by
oxidative stress, it was probable that this translation initiation
factor was involved in the cellular response to oxidative stress.
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FIGURE 4 | DAP5 is involved in cell survival under oxidative stress. (A) NIH-3T3 cells stably transfected with non-specific (NS) or DAP5-specific (sh1-DAP5 or
sh2-DAP5) inducible shRNAs were untreated or treated with doxycycline for 48 h and protein extracts were subjected to western-blotting with the indicated
antibodies. (B) The survival of stably transfected NIH-3T3 cells in the absence of Dox but treated for 24 h with H2O2 was monitored as a function of H2O2
concentration. Data are the means ± SD of three separate experiments and normalized (%) to the values obtained with H2O2-untreated cells. (C) The survival of
stably transfected NIH-3T3 cells incubated with Dox for 48 h and treated for 16 or 24 h with H2O2 was monitored as a function of H2O2 concentration. Data are the
means ± SD of five separate experiment and normalized (%) to the values obtained with H2O2-untreated cells.
This hypothesis was tested by using three pools of NIH-
3T3 fibroblasts, two of them engineered to express distinct
doxycycline-inducible shRNAs directed against DAP5 (named
sh1-DAP5 and sh2-DAP5) and one to express scrambled shRNAs
(named shNS). As compared to the shNS pool, the treatment
of cells with doxycycline for 48 h efficiently down-regulated
DAP5 protein expression in sh1-DAP5 and sh2-DAP5 pools
(Figure 4A). Before testing the possible involvement of DAP5,
survival of the three pools of NIH-3T3 cells under oxidative
stress was first monitored in the absence of doxycycline to ensure
that the processes of antibiotic selection and cell sorting (see
section “Materials and Methods”) did not generate a pool of cells
with an intrinsically (i.e., independent of DAP5 amount) distinct
response to oxidative stress. A dose effect of H2O2 during 24 h
confirmed that survival of the three pools of cells was similarly
affected by oxidative stress (Figure 4B). Then, this experiment
was repeated but in the presence (or not) of doxycycline for 48 h
to down-regulate DAP5 expression followed by treatment with
H2O2 during 16 or 24 h. The data clearly showed that DAP5
down-regulation altered cell survival under oxidative stress at
both times tested (Figure 4C).
NRF2 or NQO1 Expressions Is
Independent of DAP5 Under
Oxidative Stress
One important factor induced by and required for the response
to oxidative stress is NRF2 (recently reviewed in Bellezza et al.,
2018). NRF2 induces the transcriptional activation of genes
capable of detoxifying intracellular ROS, including NQO1 which
acts through its quinone oxidoreductase activity (Venugopal and
Jaiswal, 1996). We therefore hypothesized that NRF2 and/or
NQO1 expression could be altered at the translational level
upon down-regulation of DAP5. This assumption was supported
by the fact that oxidative stress is known to inhibit general
cap-dependent translation initiation while DAP5 is believed
to play a role in cap-independent translation under stress
(Nevins et al., 2003), and that a cap-independent mode of NRF2
mRNA translation has been described upon oxidative stress
(Li et al., 2010). The impact of oxidative stress on cap-dependent
translation was first looked in shNS and in sh2-DAP5 cells in
the absence or presence of doxycycline. In both cell pools, H2O2
treatment provoked a significant dephosphorylation of 4E-BP1,
as shown by accumulation of its α hypophosphorylated isoform
(Figure 5, left). As hypophosphorylated 4E-BP1 sequesters the
cap-binding translation initiation factor eIF4E, this supported
the notion that cap-dependent translation is actually inhibited in
our cell models, and that NRF2 (and likely NQO1) expression
could be controlled by DAP5 in a cap-independent manner. The
experiment was therefore repeated with the three pools of cells
untreated or treated with doxycycline. Both NRF2 and NQO1
expressions were actually induced upon treatment with H2O2,
but such inductions were not affected by DAP5 down-regulation
in either of the two sh1-DAP5 and sh2-DAP5 stable cell lines
(Figure 5, right). These data revealed that although required for
cell survival, DAP5 is not involved in NRF2 or NQO1 protein
induction under oxidative stress.
DISCUSSION
These data indicate that the intracellular amounts of the
three eIF4G family members are differentially regulated by
the proteasome. The DAP5 polypeptide devoid of N-terminal
PEST motifs is more stable than eIF4GI and eIF4GII proteins.
Curiously, the N-terminal segments of eIF4GI and eIF4GII
containing the functional PEST motifs are the less conserved
portions among the two proteins (Supplementary Figure S1).
The domain structures of eIF4GI and eIF4GII have been
extensively studied. As compared to their well characterized
C-terminal two-thirds, no folded domains have been identified in
their N-terminal thirds although individual shorter stretches of
amino-acids may fold upon binding to their respective partners
such as PABP and eIF4E (Marintchev and Wagner, 2005), and
likely NQO1 (Figure 3B). The N-terminal third of eIF4GI or
eIF4GII can therefore be viewed as an intrinsically disordered
and flexible segment allowing changes in conformational
states rendering eIF4GI or eIF4GII capable of creating
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FIGURE 5 | Induction of NRF2 and NQO1 proteins under oxidative stress is independent of DAP5. Protein extracts of stably transfected NIH-3T3 cells grown in the
absence or presence of doxycycline (Dox) for 48 h and untreated or treated with 1 mM H2O2 for 4 h were subjected to western-blotting with the indicated
antibodies. The bottom-to-top α–β–γ symbols denote hypo- to hyperphosphorylated 4E-BP1 isoforms.
FIGURE 6 | Conservation of N-terminal eIF4Gs’ PEST motifs among different branches of the animal kingdom. The ePESTfind software was run out for eIF4GI,
eIF4GII, or DAP5 proteins from representative species of main branches of the animal kingdom. The color code is as in Figure 1 except that PEST motifs are not
numbered. Note that for convenience, the colored boxes corresponding to the binding domains of PAPB, eIF4E, eIF4A, eIF3, and MNK1/2 validated in the
mammalian protein sequences have been copy/pasted in protein sequences of other species even if they have not been always experimentally confirmed.
numerous contacts with different proteins involved in protein
synthesis. Intrinsically disordered portions of proteins have
been often considered as probable signals for proteasomal
degradation (Suskiewicz et al., 2011). It is thus possible that
the apparently non-conserved but PEST-containing N-terminal
segment of eIF4GI or eIF4GII has yet evolved to serve a dual
function: (i) it provides a necessary flexibility for assembly
of translation initiation complexes and (ii) it forms a signal
for proteasomal degradation when not protected by binding
partners. Consistently, proteasomal degradation of eIF4GI and
eIF4GII coincides with disruption of their binding to NQO1 and
to eIF4E (next to 4E-BP1 hypophosphorylation; Figure 5 and
Alard et al., 2009), and likely with disruption of their binding
to PABP as oxidative stress leads to nuclear re-localization of
the protein where it is not expected to interact with eIF4GI
or eIF4GII (Salaun et al., 2010). Interestingly, the presence of
PEST sequences in the N-terminal third of eIF4GI or eIF4GII
is a feature conserved in animal species belonging to different
branches of the animal kingdom. Indeed while only anecdotic
(i.e., non-conserved among species) and low score PEST motifs
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were detected in eIF4GI or eIF4GII C-terminal two thirds or
in DAP5 polypeptides, eIF4GI or eIF4GII N-terminal thirds of
all species contain PEST motifs including those with the highest
scores (Figure 6).
Our data also indicate that persistent DAP5 is involved in cell
survival upon oxidative stress, although neither NRF2 nor NQO1
expression is affected by DAP5 knock-down. Whether DAP5 still
plays a role in the expression of a subset of genes through a
selective translational mechanism under oxidative stress remains
to be elucidated. If this is the case, how DAP5 could function
under oxidative stress? Clues may arise from what happens when
cells are exposed to other stresses such as hypoxia. We (Azar
et al., 2013) and others (Koritzinsky et al., 2006) have actually
shown that hypoxia blocks cap-dependent mRNA translation
through eIF4E sequestration by the hypophosphorylated forms
of 4E-BP1 and blocks global mRNA translation through eIF2α
phosphorylation. However, it has been shown recently that DAP5
selectively recruits the ribosome to target mRNAs under hypoxia
via its direct interaction with eIF2β (Liberman et al., 2015; Bryant
et al., 2018), thus circumventing the inhibitory effect of eIF4E
sequestration on cap-dependent translation and the inhibitory
effect of eIF2α phosphorylation on global translation. Together
with eIF2β and eIF2γ, eIF2α belongs to the eIF2 trimeric
translation initiation complex whose function in translation
(i.e., binding of the charged tRNA to the small ribosomal
subunit) is inhibited next to eIF2α phosphorylation (reviewed
in Lasfargues et al., 2013). Since H2O2-induced oxidative
stress also provokes eIF2α phosphorylation (MacCallum et al.,
2006) and eIF4E sequestration while sparing DAP5 (our
data), a similar DAP5-eIF2β-dependent selective translational
mechanism may occur. Additionally, DAP5 may stimulate eIF4E-
independent translation initiation of a specific subset of mRNAs
by recruiting the ribosome through its very recently described
direct interaction with eIF3 (de la Parra et al., 2018).
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